title: Histoplasma epiglottitis in a patient with Crohn's disease maintained on infliximab, prednisone, and azathioprine.
abstract: Crohn's disease is associated with treatment and non-treatment infectious complications. Among the treatment-related infectious complications, Histoplasma infection is interesting because of significant overlap between its symptoms and Crohn's disease exacerbation. It is often mistaken as Crohn's disease exacerbation. We present a case of disseminated histoplasmosis presenting as Histoplasma epiglottitis in a patient with Crohn's disease maintained on infliximab, prednisone, and azathioprine.
authors.affiliation: Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Department of Internal Medicine, Dallas, TX, USA.
authors.forename: Abdallah
authors.initials: A
authors.lastname: Abou Zahr
authors.forename: Ehab
authors.initials: E
authors.lastname: Saad Aldin
authors.forename: Pete
authors.initials: P
authors.lastname: Yunyongying
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D003424:Crohn Disease / Q000150:complications* / Q000188:drug therapy; D004359:Drug Therapy, Combination; D004826:Epiglottitis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D006658:Histoplasma; D006660:Histoplasmosis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000069285:Infliximab; D008297:Male; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000911:Antibodies, Monoclonal; D000935:Antifungal Agents; D007166:Immunosuppressive Agents; D000069285:Infliximab; D001379:Azathioprine; D011241:Prednisone